Zobrazeno 1 - 10
of 562
pro vyhledávání: '"Ottevanger, P"'
Autor:
Anne-Sophie C.A.M. Koning, MSc, PhD, Rosanne Ottevanger, MD, Maarten H. Vermeer, MD, PhD, Onno C. Meijer, MSc, PhD, Erik J. Giltay, MD, PhD
Publikováno v:
JAAD International, Vol 17, Iss , Pp 111-121 (2024)
Background: A substantial number of patients treated systemically with synthetic glucocorticoids undergo emotional disturbances during treatment. Patients with cutaneous T-cell lymphoma frequently experience skin inflammation and itching and often re
Externí odkaz:
https://doaj.org/article/412c38f401b84e0da31564122f9d16f3
Autor:
Rosanne Ottevanger, Roel E. Genders
Publikováno v:
Skin Health and Disease, Vol 4, Iss 5, Pp n/a-n/a (2024)
Externí odkaz:
https://doaj.org/article/01d8efa89e1f4c269f0142759fc253ea
Autor:
Stienen, Jozette JC, Ottevanger, Petronella B, Wennekes, Lianne, Dekker, Helena M, van der Maazen, Richard WM, Mandigers, Caroline MPW, van Krieken, Johan HJM, Blijlevens, Nicole MA, Hermens, Rosella PMG
Publikováno v:
JMIR Research Protocols, Vol 4, Iss 1, p e6 (2015)
BackgroundAn overload of health-related information is available for patients on numerous websites, guidelines, and information leaflets. However, the increasing need for personalized health-related information is currently unmet. ObjectiveThis stud
Externí odkaz:
https://doaj.org/article/776147842503416695697a2963f47411
Autor:
Ralph J. A. Maas, Janneke S. Hoogstad-van Evert, Iris M. Hagemans, Jolanda Brummelman, Diede van Ens, Paul K. J. D. de Jonge, Laura Hooijmaijers, Shweta Mahajan, Anniek B. van der Waart, Charlotte K. J. C. Hermans, Janne de Klein, Rob Woestenenk, Antonius E. van Herwaarden, Nicolaas P. M. Schaap, Somayeh Rezaeifard, Daniele V. F. Tauriello, Petra L. M. Zusterzeel, Nelleke Ottevanger, Joop H. Jansen, Willemijn Hobo, Harry Dolstra
Publikováno v:
Frontiers in Immunology, Vol 15 (2024)
Natural killer (NK) cell therapy represents an attractive immunotherapy approach against recurrent epithelial ovarian cancer (EOC), as EOC is sensitive to NK cell-mediated cytotoxicity. However, NK cell antitumor activity is dampened by suppressive f
Externí odkaz:
https://doaj.org/article/fba2485f4f604077a2047c69ad71b92f
Autor:
Rosanne Ottevanger, Esther Vermaas, Rein Willemze, Anne-Roos Schrader, Patty M. Jansen, Jelle J. Goeman, Hein Putter, Maarten H. Vermeer, Koen D. Quint
Publikováno v:
Acta Dermato-Venereologica, Vol 104 (2024)
The prognosis of patients with mycosis fungoides is variable. As the current literature is scarce and shows mixed results this study investigates the incidence of other primary malignancies in mycosis fungoides patients. A retrospective, nationwide,
Externí odkaz:
https://doaj.org/article/18e48b1ef4424bd58f911273db0bb379
Publikováno v:
JAAD Case Reports, Vol 45, Iss , Pp 34- (2024)
Externí odkaz:
https://doaj.org/article/984de0a43a87419dbc3757a8ca3b6989
Autor:
Bouke J. Koeneman, Gerty Schreibelt, Mark A. J. Gorris, Simone Hins - de Bree, Harm Westdorp, Petronella B. Ottevanger, I. Jolanda M. de Vries
Publikováno v:
Frontiers in Immunology, Vol 15 (2024)
BackgroundMetastatic endometrial cancer (mEC) continues to have a poor prognosis despite the introduction of several novel therapies including immune checkpoints inhibitors. Dendritic cell (DC) vaccination is known to be a safe immunotherapeutic moda
Externí odkaz:
https://doaj.org/article/ba90a72256674e0e9275079eb7a990e4
Autor:
Phyllis van der Ploeg, Cynthia SE. Hendrikse, Anna MJ. Thijs, Hans M. Westgeest, Huberdina PM. Smedts, M Caroline Vos, Mathilde Jalving, Christianne AR. Lok, Ingrid A. Boere, Maaike APC. van Ham, Petronella B. Ottevanger, Anneke M. Westermann, Constantijne H. Mom, Roy I. Lalisang, Sandrina Lambrechts, Ruud LM. Bekkers, Jurgen MJ. Piek
Publikováno v:
Heliyon, Vol 10, Iss 1, Pp e23170- (2024)
Objective: Ovarian cancer is the fifth cause of cancer-related death among women. The benefit of targeted therapy for ovarian cancer patients is limited even if treatment is stratified by molecular signature. There remains a high unmet need for alter
Externí odkaz:
https://doaj.org/article/ec80d08ac0c84967956ced20e2dd05ff
Autor:
Rosanne Ottevanger, Judith S. Feenstra, Liesbeth M. vanVliet, Sylvia vanBeugen, Andrea W. M. Evers, Cees Kennedy, Rein Willemze, Maarten H. Vermeer, Koen D. Quint
Publikováno v:
Skin Health and Disease, Vol 3, Iss 6, Pp n/a-n/a (2023)
Abstract Erythrodermic mycosis fungoides and Sézary syndrome are chronic, relapsing‐remitting diseases that greatly impacts patients' quality of life (QoL). Mogamulizumab‐kpkc (Mogamulizumab) is a novel therapeutic agent for cutaneous T‐cell l
Externí odkaz:
https://doaj.org/article/f6a5358fb7c94099a47f6572a42ae63e
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.